Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Heitner

Howard Heitner, Tuckahoe, NY US

Patent application numberDescriptionPublished
20100116750SILANE SUBSTITUTED POLYALKYLENE OXIDE REAGENTS AND METHODS OF USING FOR PREVENTING OR REDUCIN ALUMINOSILICATE SCALE IN INDUSTRIAL PROCESSES - Materials and methods are provided whereby polymers with least 0.5 mole % of the pendant group or end group containing —Si(OR″)05-13-2010
20100120995SILANE SUBSTITUTED POLYALKYLENE OXIDE REAGENTS AND METHODS OF USING FOR PREVENTING OR REDUCING ALUMINOSILICATE SCALE IN INDUSTRIAL PROCESSES - Materials and methods are provided whereby polymers with least 0.5 mole % of the pendant group or end group containing —Si(OR″)05-13-2010

Howard I. Heitner, Stamford, CT US

Patent application numberDescriptionPublished
20090018295POLYMERS FOR PREVENTING OR REDUCING ALUMINOSILICATE SCALE IN A BAYER PROCESS - Materials and a process are provided whereby polymers with the pendant group or end group containing —Si(OR″)01-15-2009

Patent applications by Howard I. Heitner, Stamford, CT US

Howard I. Heitner, Tuckahoe, NY US

Patent application numberDescriptionPublished
20080257827USE OF SILICON-CONTAINING POLYMERS TO IMPROVE RED MUD FLOCCULATION IN THE BAYER PROCESS - The suspended solids content of a Bayer process stream is reduced by contacting the stream with silicon-containing polymers.10-23-2008
20090099328Hydrophobically Modified Polyamine Scale Inhibitors - Hydrophobically modified Si-containing polyamines are useful for treating scale in industrial process streams. Preferred hydrophobically modified Si-containing polyamines are particularly useful for treating aluminosilicate scale in difficult-to-treat industrial process streams, such as in the Bayer alumina process streams, nuclear waste streams and kraft paper mill effluent streams04-16-2009

Mark A. Heitner, Burlingame, CA US

Patent application numberDescriptionPublished
20090182680SYSTEM AND METHOD FOR ANONYMIZED DISCLOSURE OF CORPORATE DATA IN ELECTRONIC NEGOTIATIONS - An automated electronic negotiation system permits anonymous negotiations between one or more buyer entities and one or more seller entities. Each buyer entity and seller entity registers and provides information related to the respective entity. The information is stored confidentially and released in a step-wise fashion only upon authorization. The buyer and seller are represented by respective agents. The agents are typically software modules that conduct negotiations in accordance with a predetermined set of rules. The respective agents disclose information in response to requests during the negotiation process. Disclosures may be preauthorized or require explicit authorization of the information owner. Buyer and seller entities are assigned pseudo identities for initial negotiations. Disclosure of the true identity of the party must be explicitly authorized during the negotiation process. The system is applicable to purchases and sales of assets, mergers and acquisitions, joint ventures, partial sale of assets, and the like.07-16-2009

Stefan Heitner, Fuerth DE

Patent application numberDescriptionPublished
20100210860METHOD FOR THE PREPARATION OF DRONABINOL - The present invention relates to a method for the preparation of dronabinol ((6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, Δ08-19-2010

Tara Heitner, Kobenhavn V. DK

Patent application numberDescriptionPublished
20110104058DIMERIC MOLECULAR COMPLEXES - Dimeric molecular complexes comprising an IgE CH4 dimerization domain useful for diagnostics and therapeutics.05-05-2011

Tara Heitner, Kopenhagen DE

Patent application numberDescriptionPublished
20110027268ANTI-MESOTHELIN ANTIBODIES AND USES THEREOF - The present invention provides recombinant antigen-binding regions and antibodies and functional fragments containing such antigen-binding regions that are specific for the membrane-anchored, 4O.kDa mesothelin polypeptide, which is overexpressed in several tumors, such as pancreatic and ovarian tumors, mesothelioma and lung cancer cells. These antibodies, accordingly, can be used to treat these and other disorders and conditions. Antibodies of the invention also can be used in the diagnostics field, as well as for further investigating the role of mesothelin in the progression of disorders associated with cancer. The invention also provides nucleic acid sequences encoding the foregoing antibodies, vectors containing the same, pharmaceutical compositions and kits with instructions for use.02-03-2011

Tara Renee Heitner, Copenhaven DK

Patent application numberDescriptionPublished
20110045990STRUCTURAL NUCLEIC ACID GUIDED CHEMICAL SYNTHESIS - Disclosed is a composition comprising a nucleic acid and a chemical compound, said composition forming a star structure defining 3 or more stems extending from a reaction center. The stems are formed by a nucleic acid duplex and the chemical compound has been formed in the reaction center as the reaction product of 3 or more chemical groups.02-24-2011